CLL/SLL: Update and Other Things You Should Know



 

This presentation will cover the basic diagnosis of CLL/SLL. Additionally, recommended testing and a review the effects of targeted therapies on various assays will be discussed.

Originally published on July 6, 2021


Lecture Presenter

David P. Ng, MD

David P. Ng, MD

Assistant Clinical Professor
University of Utah School of Medicine
Medical Director, Hematopathology
ARUP Laboratories

Dr. David P. Ng is a medical director of hematopathology at ARUP Laboratories and an assistant clinical professor of pathology at the University of Utah. Dr. Ng received his medical degree from the University of Illinois at Chicago College of Medicine. He then completed an anatomic and clinical pathology residency at Dartmouth-Hitchcock Medical Center and a hematopathology fellowship at the University of Washington. Dr. Ng is board certified in anatomic and clinical pathology and hematology. He is the recipient of the Janis Giorgi Young Investigator award and the John H. Rippey Grant for Laboratory Quality Assurance. His research interests include minimal residual disease testing, clinical flow cytometry, and deep learning applications in flow cytometry.


Objectives

After this presentation, participants will be able to:

  • Describe the process of diagnosing CLL/SLL
  • Differentiate between diagnosis, prognosis, and theranosis
  • Recognize interference of assays in the setting of targeted therapies

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories